By Ilan Zipkin
Staff Writer

Aurora Biosciences Corp. hopes it has turned the corner on building a sustainable toolkit company based on contract revenues, finally moving from its technology development alliances to selling finished products and services. As it completes development of its Ultra-High Throughput Screening System (UHTSS), scheduled for year end, ABSC plans to achieve breakeven this year through additional partnerships for its drug discovery technology.